Oscar Health (OSCR) president granted 106,458 RSUs and sells 7,453 shares

Rhea-AI Filing Summary

Oscar Health, Inc. reported that executive Janet Liang, President, Oscar Insurance, received a grant of 106,458 shares of Class A common stock as restricted stock units at $0.00 per share. These RSUs will vest quarterly in 12 equal installments beginning on June 1, 2026, contingent on her continued service. On the same day, she sold 7,453 shares of Class A common stock in an open-market transaction at a weighted average price of $13.39 per share under a pre-arranged Rule 10b5-1 instruction, solely to cover tax withholding on previously vested equity awards. After these transactions, she directly holds 271,532 shares of Class A common stock.

Insights

Equity compensation and governance analyst

Routine equity grant offset by tax-related share sale; overall impact is neutral.

The filing shows a sizeable equity incentive for Oscar Health executive Janet Liang via 106,458 RSUs, vesting quarterly over 12 installments from June 1, 2026. This structure ties compensation to ongoing service and long-term share performance.

The same day, she sold 7,453 shares at a weighted average of $13.39 under a pre-established Rule 10b5-1 plan, specifically to cover tax withholding from earlier equity vesting. Such sales are administrative rather than discretionary portfolio moves.

Post-transaction, Liang holds 271,532 shares of Class A common stock directly, indicating continued exposure to the stock. Overall, the combination of a compensatory grant and tax-driven sale is typical for senior executives and does not on its own signal a change in business outlook.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Liang Janet

(Last) (First) (Middle)

75 VARICK STREET, 5TH FLOOR

(Street)

NEW YORK NY 10013

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Oscar Health, Inc. [ OSCR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Oscar Insurance

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/02/2026		A		106,458(1)	A	$0	278,985(2)	D
Class A Common Stock	03/02/2026		S		7,453(3)	D	$13.39(4)	271,532	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares represent restricted stock units, which will vest quarterly in 12 equal installments beginning on June 1, 2026, subject to the reporting person's continuous service through each vesting date.

2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.

3. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Remarks:

	/s/ Melissa Curtin, Attorney-in-fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Oscar Health (OSCR) report for Janet Liang?

Oscar Health reported that executive Janet Liang received 106,458 restricted stock units and sold 7,453 shares of Class A common stock. The sale was made under a Rule 10b5-1 instruction to cover tax withholding on previously vested equity awards.

How many Oscar Health (OSCR) shares were granted to Janet Liang and how do they vest?

Janet Liang was granted 106,458 restricted stock units of Class A common stock. These RSUs will vest quarterly in 12 equal installments beginning June 1, 2026, and each vesting is conditioned on her continued service with Oscar Health through the relevant vesting date.

At what price did Janet Liang sell Oscar Health (OSCR) shares and how many?

She sold 7,453 shares of Oscar Health Class A common stock at a weighted average price of $13.39 per share. The filing notes individual trades ranged from $13.00 to $13.85, and the company can provide detailed breakdowns upon request.

Why did Janet Liang’s Oscar Health (OSCR) share sale occur under a Rule 10b5-1 plan?

The sale was executed under a Rule 10b5-1 instruction letter entered on August 8, 2025. It was specifically structured to satisfy her tax withholding obligations that arose from the vesting of previously granted equity awards, rather than as a discretionary share sale.

How many Oscar Health (OSCR) shares does Janet Liang own after these transactions?

Following the March 2, 2026 transactions, Janet Liang directly owns 271,532 shares of Oscar Health Class A common stock. This figure reflects her holdings after both receiving the new restricted stock unit grant and selling 7,453 shares to cover related tax obligations.

What type of security was involved in Janet Liang’s Oscar Health (OSCR) Form 4 filing?

All transactions involved Oscar Health’s Class A common stock. One transaction was an award of 106,458 shares in the form of restricted stock units, and the other was an open-market sale of 7,453 shares associated with equity award tax withholding requirements.